当前位置:首页 - 行情中心 - 海辰药业(300584) - 财务分析 - 现金流量表

海辰药业

(300584)

  

流通市值:28.33亿  总市值:41.40亿
流通股本:8210.99万   总股本:1.20亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金154,373,379.56644,155,755.46454,087,572.94313,542,042.48
  收到的税费返还13,179,604.2217,883,14417,883,14411,216,039.69
  收到其他与经营活动有关的现金632,792.232,008,971.415,756,342.61,648,650.96
  经营活动现金流入小计168,185,776.01664,047,870.87477,727,059.54326,406,733.13
  购买商品、接受劳务支付的现金17,935,666.3558,711,474.6729,274,321.7318,349,449.75
  支付给职工以及为职工支付的现金24,537,637.7973,950,268.1256,591,262.337,288,297.43
  支付的各项税费36,450,300.89100,128,343.0870,015,508.7448,179,255.42
  支付其他与经营活动有关的现金78,647,649.92353,168,652.13263,359,297.98156,951,984.42
  经营活动现金流出小计157,571,254.95585,958,738419,240,390.75260,768,987.02
  经营活动产生的现金流量净额10,614,521.0678,089,132.8758,486,668.7965,637,746.11
二、投资活动产生的现金流量:
  收回投资收到的现金-1,000,344.951,000,344.951,000,344.95
  处置固定资产、无形资产和其他长期资产收回的现金净额37,134.8829,500,00059,076,534.1129,180,406.06
  投资活动现金流入小计37,134.8830,500,344.9560,076,879.0630,180,751.01
  购建固定资产、无形资产和其他长期资产支付的现金13,113,744.1162,639,934.1157,109,231.5239,258,022.71
  投资支付的现金-9,100,0009,100,0009,100,000
  投资活动现金流出小计13,113,744.1171,739,934.1166,209,231.5248,358,022.71
  投资活动产生的现金流量净额-13,076,609.23-41,239,589.16-6,132,352.46-18,177,271.7
三、筹资活动产生的现金流量:
  吸收投资收到的现金-33,500,00015,000,000-
  其中:子公司吸收少数股东投资收到的现金-33,500,00015,000,000-
  取得借款收到的现金48,000,000234,300,000169,500,000115,500,000
  收到其他与筹资活动有关的现金9,919,111.1118,600,00018,600,00018,600,000
  筹资活动现金流入小计57,919,111.11286,400,000203,100,000134,100,000
  偿还债务支付的现金37,890,000222,100,000161,300,000101,200,000
  分配股利、利润或偿付利息支付的现金1,741,315.0919,504,656.9617,699,582.3415,820,205.41
  支付其他与筹资活动有关的现金10,776,134.7861,229,869.0646,089,174.1539,089,174.15
  筹资活动现金流出小计50,407,449.87302,834,526.02225,088,756.49156,109,379.56
  筹资活动产生的现金流量净额7,511,661.24-16,434,526.02-21,988,756.49-22,009,379.56
四、汇率变动对现金及现金等价物的影响-8,046.2317,092.5919,877.4821,764.18
五、现金及现金等价物净增加额5,041,526.8420,432,110.2830,385,437.3225,472,859.03
  加:期初现金及现金等价物余额66,190,828.1145,758,717.8345,758,717.8345,758,717.83
  期末现金及现金等价物余额71,232,354.9566,190,828.1176,144,155.1571,231,576.86
补充资料:
  净利润-40,732,040.52-28,878,476.75
  资产减值准备-10,921,264.4-8,635,020.7
  固定资产和投资性房地产折旧-35,775,392.74-13,526,764.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,775,392.74-13,526,764.15
  无形资产摊销-28,189,738.5-14,879,581.42
  长期待摊费用摊销-53,966.56--
  处置固定资产、无形资产和其他长期资产的损失--482,279.37--482,279.37
  固定资产报废损失-694,556.94-332,529.09
  公允价值变动损失-22,693,335.71--
  财务费用-6,586,067.09-3,447,312.21
  投资损失-3,592,696.24-1,225,456.46
  递延所得税--14,395,984.3--5,894,949.34
  其中:递延所得税资产减少--5,494,658.59--1,662,683.22
    递延所得税负债增加--8,901,325.71--4,232,266.12
  存货的减少-2,258,633.79--1,685,688.6
  经营性应收项目的减少--70,774,028.9--4,122,420.6
  经营性应付项目的增加-11,675,838.85-6,669,810.12
  不涉及现金收支的投资和筹资活动金额其他项目-2,044,418.59--
  现金的期末余额-66,190,828.11-71,231,576.86
  减:现金的期初余额-45,758,717.83-45,758,717.83
  现金及现金等价物的净增加额-20,432,110.28-25,472,859.03
公告日期2026-04-252026-04-252025-10-232025-08-23
审计意见(境内)标准无保留意见
TOP↑